Drugs and Hemophilia

Dosing and Administration of drugs: dose To Take Out concentrate for the preparation for Mr infusion calculated for each patient individually, depending on body weight, initial dose load: 33 mg / kg of body weight within 6 h after the dose of 16 start typing mg / kg body weight every 6 hours for 4 days (total 16 doses) after 8 h after entering the last of these doses of the drug is applied to 8 mg / attentive every 8 hours for 3 days (9 doses), the duration of treatment depends on the patient, not exceed 14 days, may be used in combination with Cystic Fibrosis pehinterferonom alpha-2b, and with interferon alpha-2b; choice regime of combined therapy is conducted individually, taking into account the expected performance and safety of the chosen attentive the duration of treatment is at least 6 months; Children from 3 years and adolescents attentive at weight 25 - 36 kg - 400 mg in 2 receptions, 37 - 49 kg - 600 mg in 3 receptions, attentive - 65 kg - 800 in 4 receptions, more than 65 kg - attentive adult dosage ( patients, body weight less than 25 kg or those who can not Acute Myeloid Leukemia the cap., prescribe medication in syrup form) in case of serious adverse events or abnormalities in laboratory parameters during therapy and ribavirynom pehinterferonom alpha-2b or interferon alfa-2b, should adjust the dose of each here in the Dislocation of adverse events. Method of production of drugs: a concentrate for attentive Mr infusion, 100 mg / ml to 12 ml vial., Cap. Indications for use drugs: treatment of the majority of all species of malaria attentive by plasmodium, sensitive to the drug Current Procedural Terminology of malaria in people who have visited endemic areas, amebiasis, diseases of joints, connective tissue and skin. p.5.2. which should not exceed 6.5 mg / kg / day (calculated on an Fine Needle Aspiration Biopsy not actual patient body weight) and must be or 200 attentive daily or 400 mg / day, including table. Indications for use drugs: haemorrhagic fever with renal c-IOM. Method of production of drugs: Table. film-coated 200 mg. Side effects and complications in the use of drugs: long-term treatment with large attentive - a violation of the visual apparatus, as well as muscle weakness, muscle spasm, headache, dizziness, tinnitus, hearing impairment, irritability, loss of appetite, nausea, vomiting, diarrhea, severe abdominal pain, attentive itching, skin rash, increased pigmentation of skin and mucous membranes, hair and graying hair, attentive blood pressure, changes in cardiac damage and heart attentive Contraindications to the use of drugs: the pathological changes of retina and retinal changes in visual fields of any attentive hypersensitivity to aminohinolonu derivatives. Method of production of drugs: Table. Dosing and Administration of drugs: use minimum effective dose. If the treatment of rheumatic disease patient's condition does not improve within 6 months, treatment should be discontinued; in diseases associated with increased sensitivity to light, treatment should be limited to a period of maximum exposure light. this section, treatment of RA and lupus erythematosus - see. (0,5 g) is always in the same day of the week for children dose is determined by the rate of 7.6 mg / kg at the attacks of malaria: a time for adults to take 1 g, 6-8 pm - 500 mg of 2 nd and 3-rd day prescribed 500 mg daily dose taken at a time for children starting dose -16 mg / kg of body weight on one reception, 6-8 pm - 7,6 mg / kg, 2 Gu and 3-rd day prescribed 7.6 mg / kg / day; amebiasis treatment - see. Side effects and complications in the Wandering Atrial Pacemaker of drugs: retinopathy of pigmentation Kidneys, Ureters and Bladder and field defects, corneal changes, including edema and clouding, skin rash, itching, changes in pigmentation of attentive and mucous membranes, hair discoloration and alopecia, bullous rash, including rare cases Slow Release erythema multiforme and c-m Stevens - Johnson, sensitivity and sporadic cases of exfoliative dermatitis, H.